. S6K1 re-expression in depleted S6K1 ESCs (A) Total S6K1 protein and -actin protein levels from CCE (StemCell Technologies) ESC lines (shNS, shS6K1, LV-S6K1, and shS6K1+LV-S6K1) were assessed by western blot. (B) Adipocyte marker aP2 and S6K1 protein levels from shNS and shS6K1 EBs were determined by western blot. (C) Adipocyte differentiation of WT and S6K1 -/-EBs was assessed as in Figure 4E and normalized to EB size and number. Values in C are given as mean  SEM. 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Plasmids
For overexpression, the p70-S6K1 (NM_031985) or GFP cDNA were cloned into the pLenti6-V5 lentiviral plasmid (Invitrogen). shRNA plasmids were obtained by MISSION™ TRC-Mm 1.0 (Mouse). Two distinct S6K1-specific shRNAs from the library were used: TRCN0000022904 (shS6K1(1)) and TRCN0000022905 (shS6K1(2)). The non-silencing vector, SHC002V (SigmaAldrich), was used as a negative control.
Lentiviruses infections for the generation of primary and stable cell lines
Lentiviruses were produced in 293FT cells by transfection using Lipofectamine reagent (Invitrogen). Supernatants collected 48 hours after transfection were used to infect cells. The infection efficiency of overexpression vectors was monitored by assessing the presence of GFP or by blasticidin selection of 10-fold serial dilution infections. Colony number was counted to measure pfu/ml. Primary ADSCs and MEFs were infected prior to confluence at moi 1, and efficiency of infection was assessed by either GFP expression or by antibiotic resistance. Established 3T3-L1 and ESC cell lines were generated by lentivirus infection and selected with either 2µg/ml blasticidin or 1µg/ml puromycin to obtain stable cell lines.
Protein extracts and blotting
Cells were incubated in lysis buffer containing 50 mM Tris-HCl (pH 7.5), 120 mM NaCl, 1 mM EDTA, 1% NP40, 10 mM pyrophosphate, 10 mM -glycerophosphate, 50 mM sodium fluoride, 1.5 mM sodium orthovanadate, 10 µM okadaic acid, 10 µg/ml aprotinin, and 10 µg/ml leupeptin. After lysis, insoluble material was removed by centrifugation at 12,000x g for 10 minutes at 4°C. Protein content was determined by the Bradford protein assay (BioRad). Equal amounts of protein were treated with Laemmli sample buffer. Proteins were separated by SDS-PAGE and transferred to ECL-Hybond nitrocellulose membranes (GE healthcare). The membranes were blocked for 1 hour with 10% nonfat dry milk in TBS containing 0.1 % (v/v) Tween-20 and incubated overnight with primary antibody. Primary antibodies were detected with horseradish peroxidase-coupled secondary antibody (GE Healthcare) and enhanced chemiluminescence (Pierce).
Immunohistochemistry
Cultured EBs were collected after 6 days and fixed in 4% paraformaldehyde. Paraffin-embedded sections were deparaffinized in xylene and rehydrated in a descending graded alcohol series. Endogenous peroxidase was blocked by 3% H 2 O 2 (10min). Antigen retrieval was achieved by microwaving (10min) specimens in citrate buffer (pH6.0). After blocking non-specific binding sites with normal swine serum (1h, RT) in TBST/1%Tween, sections were incubated overnight with or without rabbit anti-phospho S6 (Ser240/244) antibody (1/100 dilution, Cell Signaling). After 4 washes with TBS/1%Tween(TBS-T), the sections were incubated for 45 min with horseradish peroxidase-conjugated swine anti-rabbit secondary antibodies (Dako), washed again, and then incubated for 30 min with AB reagents (Vector Laboratories). DAB (Vector Laboratories) served as the chromagen, and hematoxylin was used as a nuclear counter stain.
3T3-L1 cell culture and adipocyte differentiation
3T3-L1 preadipocytes were grown to confluence (d0) in DMEM (high Glucose, Hyclone) containing 10% Bovine Serum (Heat-inactivated, GIBCO). Cell lines expressing either shS6K1 (1) and (2), or control vector were obtained by selection with 1µg/ml puromycin for a period of 2 weeks, with fresh medium added every two days. Adipocytic differentiation was induced by treating confluent cells (d0) for 48 hours in differentiation medium: DMEM supplemented with 10% Fetal Bovine Serum (FCS) (Hyclone), 500 µM 3-Isobutyl-1-methylxanthine (IBMX) (Sigma-Aldrich), 1µM dexamethasone (DEX) (Sigma-Aldrich), and 10µg/ml insulin (Sigma-Aldrich). Afterwards, cells were exposed to maturation medium (DMEM supplemented with 10% FCS and 10µg/ml insulin), with fresh medium added every 2 days until d10 when cells were harvested for protein and RNA analyses or fixed for Oil Red O staining.
Oil Red O staining and triglyceride content measurement Cells grown in tissue-culture dishes were washed twice with PBS and fixed with 4% PBS-buffered formaldehyde for at least 1 hour at room temperature. The cells were then stained for 2 hours at room temperature with a filtered 0.5% Oil Red O (Sigma-Aldrich) solution (in isopropanol), extensively washed with distilled water, and visualized. Oil Red O staining was extracted with isopropanol and measured spectrophotometrically at 510 nm (RamirezZacarias et al., 1992) . Triglyceride content was determined after lipid extraction using the Triglycerides Kit (Thermo Scientific).
Quantitative real-time polymerase chain reaction (qPCR)
Total RNA was extracted from frozen tissue samples or from cells by using the RNeasy kit (Qiagen). Complementary DNA was synthesized from total RNA with the SuperScript III First-Strand Synthesis System for qPCR (Invitrogen). The qPCR measurement of individual cDNAs was performed by using SYBR green dye to measure duplex DNA formation with the Mastercycler® ep Realplex system and normalized to the expression of 18S ribosomal RNA. The following primers were used in the real time qPCR: 
FACS analysis of early adipocyte progenitor cells
SVFs isolated from epididymal fat pads were resuspended in ice-cold DMEM/2%FBS (Hyclone) for labeling. Antibody incubations were performed on ice for 1 hour. After incubation, cells were washed and resuspended in fresh DMEM/10%FBS for analysis. Samples were sorted and analyzed on a BD FACSAria cell sorter and analyzed with BD FACSDiva software (BD Biosciences). For sorting and analysis, cells were initially selected by size on the basis of forward scatter (FSC) and side scatter (SSC), and separated on the basis of the cell-surface markers. Conjugated antibodies (Ter119-PE, CD29-Alexa700, CD34-APC, Sca-1-FITC, and CD24-PacificBlue) were purchased from BioLegend .
Microarray Analysis
Total RNA was isolated using the RNeasy kit (QIAGEN, Valencia, CA) according to the manufacturer's instructions. To verify RNA quality before labeling for microarray analyses, samples were analyzed using an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). Approximately 1μg of total RNA was used as a template for cDNA synthesis for the microarrays. Labeling of cDNAs, preparation of microarrays, and hybridization reactions (Affymetrix mouse 430 2.0. A) were performed by the University of Cincinnati Functional Genomics Core (Cincinnati, OH), and specific details of the labeling protocols can be found at http://microarray.uc.edu. The statistical analyses were performed by the University of Cincinnati Bioinformatics Core. Genes were selected on the basis of FDR-adjusted p-value < 0.1 and fold change > 1.5.
